LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 21.40 | 84.90 | 1369 | 1454 | 0.9411 | 0.9706 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 21.40 | 84.90 | 1573 | 1454 | 1.0813 | 1.0385 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 21.40 | 84.90 | 1684 | 1454 | 1.1577 | 1.0727 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 23.10 | 84.90 | 24 | 1616 | 0.0149 | -0.2571 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 23.10 | 84.90 | 1442 | 1616 | 0.8922 | 0.9471 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 23.10 | 84.90 | 1688 | 1616 | 1.0444 | 1.0206 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 23.10 | 84.90 | 1788 | 1616 | 1.1063 | 1.0481 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.81 | 84.90 | 22 | 1769 | 0.0124 | -0.2652 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.81 | 84.90 | 1573 | 1769 | 0.8890 | 0.9470 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.81 | 84.90 | 1894 | 1769 | 1.0704 | 1.0313 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.81 | 84.90 | 1984 | 1769 | 1.1212 | 1.0529 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 26.51 | 84.90 | 28 | 1923 | 0.0146 | -0.2184 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 26.51 | 84.90 | 1663 | 1923 | 0.8647 | 0.9365 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 26.51 | 84.90 | 2038 | 1923 | 1.0597 | 1.0259 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 26.51 | 84.90 | 2116 | 1923 | 1.1003 | 1.0429 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 28.21 | 84.90 | 43 | 2091 | 0.0206 | -0.1368 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 28.21 | 84.90 | 1836 | 2091 | 0.8778 | 0.9444 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 28.21 | 84.90 | 2222 | 2091 | 1.0624 | 1.0264 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 28.21 | 84.90 | 2286 | 2091 | 1.0930 | 1.0388 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 29.92 | 84.90 | 39 | 2237 | 0.0174 | -0.1519 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 29.92 | 84.90 | 1995 | 2237 | 0.8915 | 0.9519 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 29.92 | 84.90 | 2402 | 2237 | 1.0734 | 1.0302 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 29.92 | 84.90 | 2467 | 2237 | 1.1025 | 1.0418 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 31.62 | 84.90 | 35 | 2449 | 0.0143 | -0.1670 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 31.62 | 84.90 | 2128 | 2449 | 0.8687 | 0.9428 | MN20160318_Q02 | D22 |